153 related articles for article (PubMed ID: 7736396)
41. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
42. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
[TBL] [Abstract][Full Text] [Related]
43. Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma.
Chen CA; Cheng WF; Lee CN; Su YN; Hsieh CY; Hsieh FJ
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):591-7. PubMed ID: 15144343
[TBL] [Abstract][Full Text] [Related]
44. [Color doppler ultrasonography of uterine vessels during radiotherapy of advanced cervix cancers].
Stummvoll W; Ruschitzka G; Hammer J
Gynakol Geburtshilfliche Rundsch; 1994; 34(2):102-5. PubMed ID: 7950434
[TBL] [Abstract][Full Text] [Related]
45. The use of polymerase chain reaction to detect metastatic cancer cells within lymph nodes in stage I cervical carcinoma.
Hording U; Ravn V; Knudsen J; Visfeldt J
Int J Gynecol Pathol; 1995 Oct; 14(4):339-43. PubMed ID: 8598337
[TBL] [Abstract][Full Text] [Related]
46. Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors.
Li P; Ma J; Zhang X; Guo Y; Liu Y; Li X; Zhao D; Wang Z
Diagn Pathol; 2018 May; 13(1):31. PubMed ID: 29788963
[TBL] [Abstract][Full Text] [Related]
47. Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection.
Dabić MM; Nola M; Tomicić I; Dotlić S; Petrovecki M; Jukić S
Acta Obstet Gynecol Scand; 2008; 87(3):366-72. PubMed ID: 18307079
[TBL] [Abstract][Full Text] [Related]
48. Three-dimensional power Doppler imaging of early-stage cervical cancer.
Hsu KF; Su JM; Huang SC; Cheng YM; Kang CY; Shen MR; Chang FM; Chou CY
Ultrasound Obstet Gynecol; 2004 Nov; 24(6):664-71. PubMed ID: 15517537
[TBL] [Abstract][Full Text] [Related]
49. Blood flow after intraarterial infusion chemotherapy in a patient with advanced cervical cancer.
Minagawa Y; Onohara Y; Takahashi H; Tsudo T
Gynecol Obstet Invest; 2001; 52(4):278-80. PubMed ID: 11729345
[TBL] [Abstract][Full Text] [Related]
50. [HPV 16 DNA occurrence in lymph nodes of patients with cervical carcinoma].
Łukaszuk K; Liss J; Gulczyński J; Woźniak I; Emerich J; Wójcikowski C
Ginekol Pol; 2003 Feb; 74(2):87-90. PubMed ID: 12715415
[TBL] [Abstract][Full Text] [Related]
51. Color Doppler assessment of blood flow in endometrial cancer.
Sawicki V; Spiewankiewicz B; Stelmachów J; Cendrowski K
Eur J Gynaecol Oncol; 2005; 26(3):279-84. PubMed ID: 15991526
[TBL] [Abstract][Full Text] [Related]
52. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
[TBL] [Abstract][Full Text] [Related]
53. [Contrast ultrasound using SonoVue for pelvic radiation with concurrent chemotherapy monitoring in stage IB-II cervical cancer].
Marret H; Barillot I; Rolland Y; Lévèque J
Cancer Radiother; 2009 Oct; 13(6-7):515-9. PubMed ID: 19726215
[TBL] [Abstract][Full Text] [Related]
54. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
[TBL] [Abstract][Full Text] [Related]
55. Transvaginal color Doppler sonography in predicting the response to chemotherapy in advanced cervical cancer.
Greco P; Cormio G; Vimercati A; Loverro G; Selvaggi L
Ultrasound Obstet Gynecol; 1997 Jan; 9(1):49-52. PubMed ID: 9060131
[TBL] [Abstract][Full Text] [Related]
56. Type of human papillomavirus and expression of p53 in elderly women with cervical cancer.
Saito J; Hoshiai H; Noda K
Gynecol Obstet Invest; 2000; 49(3):190-3. PubMed ID: 10729761
[TBL] [Abstract][Full Text] [Related]
57. Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
J Obstet Gynaecol; 2021 Oct; 41(7):1116-1120. PubMed ID: 33427547
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.
Paz IB; Cook N; Odom-Maryon T; Xie Y; Wilczynski SP
Cancer; 1997 Feb; 79(3):595-604. PubMed ID: 9028373
[TBL] [Abstract][Full Text] [Related]
59. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
[TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma.
Ikenberg H; Wiegering I; Pfisterer J; Kiechle-Schwarz M; Schmitt B; Sauerbrei W; Pfleiderer A
Cancer J Sci Am; 1996; 2(1):28-34. PubMed ID: 9166495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
